Addiction Research

According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.

Addiction Research Products Targets

Products for Addiction Research

Cat.No. Product Name Information/Activity
BCC7336 A 80426 mesylate 152148-64-6
BCC5033 Amitriptyline HCl Amitriptyline hydrochloride is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA).
BCC7925 Bicifadine hydrochloride 66504-75-4
BCC5901 BTS 54-505 hydrochloride 84484-78-6
BCC7063 Citalopram hydrobromide Citalopram hydrobromide is an antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class.
BCC5036 Clomipramine HCl Clomipramine hydrochloride is a serotonin transporter (SERT), norepinephrine transporter (NET) and dopamine transporter (DAT) blocker with Ki of 0.14, 54 and 3 nM, respectively.
BCC5943 Cocaine hydrochloride 53-21-4
BCC5064 Dapoxetine HCl Dapoxetine hydrochloride is a short-acting novel selective serotonin reuptake inhibitor(SSRI).
BCC5927 Dexfenfluramine hydrochloride 3239-45-0
BCC3773 Duloxetine HCl Duloxetine hydrochloride ((S)-Duloxetine hydrochloride) is a serotonin-norepinephrine reuptake inhibitor (SNRI) with a Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anxiety disorder (GAD).